SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-092322
Filing Date
2016-01-29
Accepted
2016-01-29 07:53:53
Documents
9
Period of Report
2016-01-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-2967_18k.htm 8-K 25008
2 EX-99.1 a16-2967_1ex99d1.htm EX-99.1 613450
3 GRAPHIC g29671mm03i001.jpg GRAPHIC 2076
4 GRAPHIC g29671mm07i001.gif GRAPHIC 2615
5 GRAPHIC g29671mm11i001.jpg GRAPHIC 1900
6 GRAPHIC g29671mm01i001.gif GRAPHIC 2615
7 GRAPHIC g29671mm13i001.jpg GRAPHIC 2058
8 GRAPHIC g29671mm05i001.gif GRAPHIC 2615
9 GRAPHIC g29671mm09i001.jpg GRAPHIC 1900
  Complete submission text file 0001104659-16-092322.txt   662334
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 161370985
SIC: 2834 Pharmaceutical Preparations